Literature DB >> 26507982

Present and future role of FDG-PET/CT imaging in the management of head and neck carcinoma.

Kazuhiro Kitajima1, Yuko Suenaga2, Kazuro Sugimura3.   

Abstract

Integrated positron emission tomography/computed tomography (PET/CT) with 2-[(18)F]fluoro-2-deoxy-D-glucose (FDG) is a useful technique for acquisition of both glucose metabolic and anatomic imaging data using a single device in a single diagnostic session, and has opened a new field in clinical oncologic imaging. FDG-PET/CT has been used successfully for the initial staging, restaging, monitoring of the response to therapy, and prognostication of head and neck carcinoma. The present review discusses the current role of FDG-PET/CT in the management of head and neck carcinoma, focusing on its usefulness and limitations for imaging in these patients.

Entities:  

Keywords:  Fluorodeoxyglucose (FDG); Head and neck carcinoma; Positron emission tomography/computed tomography (PET/CT); Restaging; Staging

Mesh：

Substances：

Year:  2015        PMID： 26507982     DOI： 10.1007/s11604-015-0495-1

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN： 1867-1071            Impact factor:   2.374


  105 in total

1.  Results of a prospective study of positron emission tomography-directed management of residual nodal abnormalities in node-positive head and neck cancer after definitive radiotherapy with or without systemic therapy.

Authors:  Sandro V Porceddu; David I Pryor; Elizabeth Burmeister; Bryan H Burmeister; Michael G Poulsen; Matthew C Foote; Benedict Panizza; Scott Coman; David McFarlane; William Coman
Journal:  Head Neck       Date:  2011-01-14       Impact factor: 3.147

2.  Clinical usefulness of [18F] fluoro-2-deoxy-D-glucose uptake in 178 head-and-neck cancer patients with nodal metastasis treated with definitive chemoradiotherapy: consideration of its prognostic value and ability to provide guidance for optimal selection of patients for planned neck dissection.

Authors:  Haruo Inokuchi; Takeshi Kodaira; Hiroyuki Tachibana; Tatsuya Nakamura; Natsuo Tomita; Rie Nakahara; Akinori Takada; Nobutaka Mizoguchi; Tsuneo Tamaki; Nobukazu Fuwa
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-29       Impact factor: 7.038

3.  18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI.

Authors:  Heiko Schöder; Diane L Carlson; Dennis H Kraus; Hilda E Stambuk; Mithat Gönen; Yusuf E Erdi; Henry W D Yeung; Andrew G Huvos; Jatin P Shah; Steven M Larson; Richard J Wong
Journal:  J Nucl Med       Date:  2006-05       Impact factor: 10.057

4.  Prognostic significance of 18F-FDG PET parameters and plasma Epstein-Barr virus DNA load in patients with nasopharyngeal carcinoma.

Authors:  Kai-Ping Chang; Ngan-Ming Tsang; Chun-Ta Liao; Cheng-Lung Hsu; Ming-Jui Chung; Chuan-Wei Lo; Sheng-Chieh Chan; Shu-Hang Ng; Hung-Ming Wang; Tzu-Chen Yen
Journal:  J Nucl Med       Date:  2012-01       Impact factor: 10.057

5.  Role of 18F-FDG PET in detecting primary site in the patient with primary unknown carcinoma.

Authors:  Kenichiro Yabuki; Mamoru Tsukuda; Choichi Horiuchi; Takahide Taguchi; Goshi Nishimura
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-03       Impact factor: 2.503

6.  18F-FDG PET/CT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma.

Authors:  Remy Lim; Anne Eaton; Nancy Y Lee; Jeremy Setton; Nisha Ohri; Shyam Rao; Richard Wong; Matthew Fury; Heiko Schöder
Journal:  J Nucl Med       Date:  2012-08-14       Impact factor: 10.057

7.  Detection of metachronous esophageal squamous carcinoma in patients with head and neck cancer with use of transnasal esophagoscopy.

Authors:  Yan-Ye Su; Fu-Min Fang; Hui-Ching Chuang; Sheng-Dean Luo; Chih-Yen Chien
Journal:  Head Neck       Date:  2010-06       Impact factor: 3.147

8.  Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer.

Authors:  Yutaka Yamazaki; Masaaki Saitoh; Ken-ichi Notani; Kanchu Tei; Yasunori Totsuka; Shu-ichi Takinami; Kakuko Kanegae; Masayuki Inubushi; Nagara Tamaki; Yoshimasa Kitagawa
Journal:  Ann Nucl Med       Date:  2008-05-23       Impact factor: 2.668

Review 9.  Perineural spread in head and neck malignancies: clinical significance and evaluation with 18F-FDG PET/CT.

Authors:  Fabio M Paes; Adam D Singer; Adam N Checkver; Ricardo A Palmquist; Gabriela De La Vega; Charif Sidani
Journal:  Radiographics       Date:  2013-10       Impact factor: 5.333

10.  Prognostic value of FDG PET imaging in patients with laryngeal cancer.

Authors:  Kazuhiro Kitajima; Yuko Suenaga; Tomonori Kanda; Daisuke Miyawaki; Kenji Yoshida; Yasuo Ejima; Ryohei Sasaki; Hirokazu Komatsu; Miki Saito; Naoki Otsuki; Ken-Ichi Nibu; Naomi Kiyota; Tsutomu Minamikawa; Kazuro Sugimura
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240
View more
  4 in total

1.  New Year's resolution: increase the impact factor of this journal.

Authors:  Nagara Tamaki
Journal:  Jpn J Radiol       Date:  2016-01       Impact factor: 2.374

2.  Usefulness of diffusion-weighted MR imaging for differentiating between Warthin's tumor and oncocytoma of the parotid gland.

Authors:  Hiroki Kato; Keita Fujimoto; Masayuki Matsuo; Keisuke Mizuta; Mitsuhiro Aoki
Journal:  Jpn J Radiol       Date:  2017-01-10       Impact factor: 2.374

3.  Improved detection rates and treatment planning of head and neck cancer using dual-layer spectral CT.

Authors:  Fabian K Lohöfer; Georgios A Kaissis; Frances L Köster; Sebastian Ziegelmayer; Ingo Einspieler; Carlos Gerngross; Michael Rasper; Peter B Noel; Steffen Koerdt; Andreas Fichter; Ernst J Rummeny; Rickmer F Braren
Journal:  Eur Radiol       Date:  2018-05-28       Impact factor: 5.315

4.  International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines.

Authors:  Simone de Campos Vieira Abib; Chan Hon Chui; Sharon Cox; Abdelhafeez H Abdelhafeez; Israel Fernandez-Pineda; Ahmed Elgendy; Jonathan Karpelowsky; Pablo Lobos; Marc Wijnen; Jörg Fuchs; Andrea Hayes; Justin T Gerstle
Journal:  Ecancermedicalscience       Date:  2022-02-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.